פלובוקסמין
הערות שוליים

1 2  Irons J (בדצמבר 2005). "Fluvoxamine in the treatment of anxiety disorders". Neuropsychiatric Disease and Treatment. 1 (4): 289–299. PMC 2424117. PMID 18568110. {{cite journal}}:  (עזרה)
↑  Asnis GM, Hameedi FA, Goddard AW, Potkin SG, Black D, Jameel M, Desagani K, Woods SW (באוגוסט 2001). "Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients". Psychiatry Research. 103 (1): 1–14. doi:10.1016/S0165-1781(01)00265-7. PMID 11472786. {{cite journal}}:  (עזרה)
↑  Fluvoxamine: MedlinePlus Drug Information, medlineplus.gov (באנגלית)
↑  Fluvoxamine | Side Effects, Dosage, Uses, and More, Healthline, ‏2018-05-18 (באנגלית)
↑  Westenberg HG, Sandner C (באפריל 2006). "Tolerability and safety of fluvoxamine and other antidepressants". International Journal of Clinical Practice. 60 (4): 482–491. doi:10.1111/j.1368-5031.2006.00865.x. PMC 1448696. PMID 16620364. {{cite journal}}:  (עזרה)
↑  Jc Roos, Cardiac effects of antidepressant drugs. A comparison of the tricyclic antidepressants and fluvoxamine., British Journal of Clinical Pharmacology 15, 1983-06 doi: 10.1111/j.1365-2125.1983.tb02135.x
1 2 3 4 5  R. Boland,Verduin,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 626
↑  "Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group". The New England Journal of Medicine. 344 (17): 1279–1285. באפריל 2001. doi:10.1056/NEJM200104263441703. PMID 11323729. {{cite journal}}:  (עזרה)
↑  Boaden K, Tomlinson A, Cortese S, Cipriani A (2 בספטמבר 2020). "Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment". Frontiers in Psychiatry. 11: 717. doi:10.3389/fpsyt.2020.00717. PMC 7493620. PMID 32982805. {{cite journal}}:  (עזרה)
↑  Correll CU, Cortese S, Croatto G, Monaco F, Krinitski D, Arrondo G, Ostinelli EG, Zangani C, Fornaro M, Estradé A, Fusar-Poli P, Carvalho AF, Solmi M (ביוני 2021). "Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review". World Psychiatry. 20 (2): 244–275. doi:10.1002/wps.20881. PMC 8129843. PMID 34002501. {{cite journal}}:  (עזרה)
↑  "Fluvoxamine Maleate tablet, coated prescribing information". DailyMed. U.S. National Library of Medicine. 14 בדצמבר 2018. ארכיון מ-19 באוקטובר 2020. נבדק ב-28 בנובמבר 2019. {{cite web}}:  (עזרה)
↑  "Luvox CR approved for OCD and SAD". MPR. 29 בפברואר 2008. ארכיון מ-28 באוגוסט 2021. נבדק ב-2 במרץ 2019. {{cite web}}:  (עזרה)
↑  "Luvox Tablets". NPS MedicineWise. ארכיון מ-22 באוקטובר 2018. נבדק ב-22 באוקטובר 2018. {{cite web}}:  (עזרה)
↑  Antidepressants A–Z
↑  Anatoly Boleslavovich Smulevich, Natalia Alekseevna Ilyina, Victoria Valentinovna Chitlova, Fluvoxamine in Treatment of Depression in Russian Patients: An Open-Label, Uncontrolled and Non-Randomized Multicenter Observational Study, Open Journal of Psychiatry 5, 2015-09-29, עמ' 320–329 doi: 10.4236/ojpsych.2015.54036
↑  "2005 News Releases". Astellas Pharma. אורכב מ-המקור ב-16 בספטמבר 2018. נבדק ב-16 בספטמבר 2018. {{cite web}}:  (עזרה)
1 2  Wilde MI, Plosker GL, Benfield P (בנובמבר 1993). "Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness". Drugs. 46 (5): 895–924. doi:10.2165/00003495-199346050-00008. PMID 7507038. {{cite journal}}:  (עזרה)
↑  Schreiber S, Pick CG (באוגוסט 2006). "From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram". European Neuropsychopharmacology. 16 (6): 464–468. doi:10.1016/j.euroneuro.2005.11.013. PMID 16413173. {{cite journal}}:  (עזרה)
↑  Coquoz D, Porchet HC, Dayer P (בספטמבר 1993). "Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: a study in healthy volunteers". Clinical Pharmacology and Therapeutics. 54 (3): 339–344. doi:10.1038/clpt.1993.156. PMID 8375130. {{cite journal}}:  (עזרה)
↑  Highlights Of Prescribing Information, ‏2004
↑  Dien Ho, Antidepressants and the FDA’s Black-Box Warning: Determining a Rational Public Policy in the Absence of Sufficient Evidence, AMA Journal of Ethics 14, 2012-06-01, עמ' 483–488 doi: 10.1001/virtualmentor.2012.14.6.pfor2-1206
↑  R. Boland,Verduin,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 626-627
↑  Fluvoxamine Use During Pregnancy, Drugs.com (באנגלית)
1 2 3 4 5 6 7 8  R. Boland,Verduin,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 627
↑  Medication for Kids With Depression, Child Mind Institute (באנגלית אמריקאית)
↑  What to know about antidepressants for kids and teens, Mayo Clinic (באנגלית)
1 2 3 4 5 6 7  R. Boland,Verduin,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 628
↑  Isabelle Bazin, Marion Desmarchelier, Retrospective study on the use of fluvoxamine in 72 dogs with anxiety disorders, Journal of Veterinary Behavior 50, 2022-04-01, עמ' 60–69 doi: 10.1016/j.jveb.2022.01.001
↑  The use of fluvoxamine - Dr Dehasse, www.joeldehasse.com
1 2  R. Boland,Verduin,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 628-629
1 2  Ware, Michael R. (1 במרץ 1997). "Fluvoxamine: A Review of the Controlled Trials in Depression". The Journal of Clinical Psychiatry. Physicians Postgraduate Press, Inc. 58 (suppl 5): 15–23. ISSN 0160-6689. PMID 9184623. ארכיון מ-6 בדצמבר 2022. נבדק ב-1 בדצמבר 2023. {{cite journal}}:  (עזרה)
1 2 3 4 5 6  R. Boland,Verduin,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 629
↑  R. Boland,Verduin,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 629-630
1 2 3 4 5 6 7 8 9 10  R. Boland,Verduin,Dr. Pedro Ruiz, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 630
1 2  Renoir T (2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: a review of the clinical evidence and the possible mechanisms involved". Front Pharmacol. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
1 2  Fava GA, Gatti A, Belaise C, Guidi J, Offidani E (2015). "Withdrawal Symptoms after Selective Serotonin Reuptake Inhibitor Discontinuation: A Systematic Review". Psychother Psychosom. 84 (2): 72–81. doi:10.1159/000370338. PMID 25721705.
1 2  Warner CH, Bobo W, Warner C, Reid S, Rachal J (באוגוסט 2006). "Antidepressant discontinuation syndrome". American Family Physician. 74 (3): 449–56. PMID 16913164. {{cite journal}}:  (עזרה)
1 2  R. Boland,Verduin,Dr. P, Kaplan & Sadock's Synopsis of Psychiatry, 2021, עמ' 630-631
↑  Suzuki Y, Shioiri T, Muratake T, Kawashima Y, Sato S, Hagiwara M, Inoue Y, Shimoda K, Someya T (באפריל 2003). "Effects of concomitant fluvoxamine on the metabolism of alprazolam in Japanese psychiatric patients: interaction with CYP2C19 mutated alleles". European Journal of Clinical Pharmacology. 58 (12): 829–833. doi:10.1007/s00228-003-0563-9. PMID 12698310. {{cite journal}}:  (עזרה)
↑  Fleishaker JC, Hulst LK (1994). "A pharmacokinetic and pharmacodynamic evaluation of the combined administration of alprazolam and fluvoxamine". European Journal of Clinical Pharmacology. 46 (1): 35–39. doi:10.1007/bf00195913. PMID 8005185.
↑  Ishikawa M, Ishiwata K, Ishii K, Kimura Y, Sakata M, Naganawa M, Oda K, Miyatake R, Fujisaki M, Shimizu E, Shirayama Y, Iyo M, Hashimoto K (באוקטובר 2007). "High occupancy of sigma-1 receptors in the human brain after single oral administration of fluvoxamine: a positron emission tomography study using [11C]SA4503". Biological Psychiatry. 62 (8): 878–883. doi:10.1016/j.biopsych.2007.04.001. PMID 17662961. {{cite journal}}:  (עזרה)
↑  Yahata M, Chiba K, Watanabe T, Sugiyama Y (בספטמבר 2017). "Possibility of Predicting Serotonin Transporter Occupancy From the In Vitro Inhibition Constant for Serotonin Transporter, the Clinically Relevant Plasma Concentration of Unbound Drugs, and Their Profiles for Substrates of Transporters". Journal of Pharmaceutical Sciences. 106 (9): 2345–2356. doi:10.1016/j.xphs.2017.05.007. PMID 28501470. {{cite journal}}:  (עזרה)
1 2  Sittig's Pharmaceutical Manufacturing Encyclopedia (PDF) (3rd ed.). William Andrew. 2008. p. 1699. ISBN 978-0-8155-1526-5. אורכב מ-המקור (PDF) ב-14 באוקטובר 2013. נבדק ב-17 באוקטובר 2013. {{cite book}}:  (עזרה)
↑  Leslie LK, Newman TB, Chesney PJ, Perrin JM (ביולי 2005). "The Food and Drug Administration's deliberations on antidepressant use in pediatric patients". Pediatrics. 116 (1): 195–204. doi:10.1542/peds.2005-0074. PMC 1550709. PMID 15995053. {{cite journal}}:  (עזרה)
↑  "Brand Index―Fluvoxamine India". אורכב מ-המקור ב-19 באוקטובר 2013. נבדק ב-18 באוקטובר 2013. {{cite web}}:  (עזרה)
↑  Omori IM, Watanabe N, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA (במרץ 2010). "Fluvoxamine versus other anti-depressive agents for depression". The Cochrane Database of Systematic Reviews (3): CD006114. doi:10.1002/14651858.CD006114.pub2. PMC 4171125. PMID 20238342. {{cite journal}}:  (עזרה)
↑  "OCD Medication". אורכב מ-המקור ב-14 באוקטובר 2013. נבדק ב-17 באוקטובר 2013. {{cite web}}:  (עזרה)
↑  "Fluvoxamine Product Monograph" (PDF). 1999. ארכיון (PDF) מ-27 באוקטובר 2020. נבדק ב-15 בספטמבר 2018. {{cite web}}:  (עזרה)
↑  "Luvox Approved For Obsessive Compulsive Disorder in Children and Teens". אורכב מ-המקור ב-16 בינואר 2009. נבדק ב-8 בפברואר 2014. {{cite web}}:  (עזרה)
↑  "Solvay's Fluvoxamine maleate is first drug approved for the treatment of social anxiety disorder in Japan". ארכיון מ-15 בספטמבר 2018. נבדק ב-15 בספטמבר 2018. {{cite web}}:  (עזרה)
↑  Bhuta S, Khokher W, Kesireddy N, Iftikhar S, Beran A, Mhanna M, Patel NJ, Patel M, Burmeister C, Assaly R (2022). "Fluvoxamine in Nonhospitalized Patients With Acute COVID-19 Infection and the Lack of Efficacy in Reducing Rates of Hospitalization, Mechanical Ventilation, and Mortality in Placebo-Controlled Trials: A Systematic Review and Meta-Analysis". American Journal of Therapeutics. 29 (3): e298–e304. doi:10.1097/MJT.0000000000001496. PMID 35383578.
↑  Asadi Anar M, Foroughi E, Sohrabi E, Peiravi S, Tavakoli Y, Kameli Khouzani M, Behshood P, Shamshiri M, Faridzadeh A, Keylani K, Langari SF, Ansari A, Khalaji A, Garousi S, Mottahedi M, Honari S, Deravi N (2022). "Selective serotonin reuptake inhibitors: New hope in the fight against COVID-19". Frontiers in Pharmacology. 13: 1036093. doi:10.3389/fphar.2022.1036093. PMC 9748354. PMID 36532776.
↑  "FDA declines to authorize common antidepressant as COVID treatment". Reuters. 16 במאי 2022. ארכיון מ-17 במאי 2022. נבדק ב-18 במאי 2022. {{cite news}}:  (עזרה)
↑  Ingram, Ian (17 בנובמבר 2023). "Higher-Dose Fluvoxamine Fails for COVID Outpatients". MedPage Today. ארכיון מ-17 בנובמבר 2023. נבדק ב-4 בדצמבר 2023. {{cite web}}:  (עזרה)
↑  Nyirenda JL, Sofroniou M, Toews I, Mikolajewska A, Lehane C, Monsef I, Abu-Taha A, Maun A, Stegemann M, Schmucker C (בספטמבר 2022). "Fluvoxamine for the treatment of COVID-19". The Cochrane Database of Systematic Reviews (Systematic review). 2022 (9): CD015391. doi:10.1002/14651858.CD015391. PMC 9473347. PMID 36103313. {{cite journal}}:  (עזרה)
↑  Wannigama DL, Hurst C, Phattharapornjaroen P, Hongsing P, Sirichumroonwit N, Chanpiwat K, Rad S. M. AH, Storer RJ, Ounjai P, Kanthawee P, Ngamwongsatit N, Kupwiwat R, Kupwiwat C, Brimson JM, Devanga Ragupathi NK, Charuluxananan S, Leelahavanichkul A, Kanjanabuch T, Higgins PG, Badavath VN, Amarasiri M, Verhasselt V, Kicic A, Chatsuwan T, Pirzada K, Jalali F, Reiersen AM, Abe S, Ishikawa H (באפריל 2024). "Early treatment with fluvoxamine, bromhexine, cyproheptadine, and niclosamide to prevent clinical deterioration in patients with symptomatic COVID-19: a randomized clinical trial". eClinicalMedicine. 70: 102517. doi:10.1016/j.eclinm.2024.102517. PMC 10955208. PMID 38516100. {{cite journal}}:  (עזרה)
הבהרה: המידע בוויקיפדיה נועד להעשרה בלבד ואינו מהווה ייעוץ רפואי.